Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials.
Francesco GiorginoDenise R FrancoClaudia NicolayAndrea HemmingwayAngel RodríguezRussell J WiesePublished in: Diabetes care (2024)
In this post hoc analysis, tirzepatide was associated with superior glycemic control compared with insulin, irrespective of baseline glycemic pattern.